About Progenics

To consistently provide our clients with the highest quality in processing Cord Blood and Cord Tissue samples for long term cryopreservation in our state-of-the-art processing laboratory and storage facility in order to ensure cryopreserved stem cells constantly meet current regulatory requirements and international accreditation standards for safe, secure, effective and prompt retrieval of cellular therapy product when needed for clinical use.

To be the global address of families interested in cryopreserving cellular therapy product of unmatched quality through consistency in producing highest viable yield of processed stem cells for potential clinical use. To be actively helping various ethnic groups nationally and globally by facilitating access to our unmatched quality services in cryopreservation of cellular therapy product.

We are Proudly Canadian!

We were founded in 2004, and have successfully banked cord blood for over 21,000 famillies. Progenics is a Health Canada and FDA registered and AABB accredited facility with experience in processing cord blood for successful transplantation.

Our Shared Core Values

Integrity
Innovation 
Accountability
Ethical Behavior
Knowledge Transfer
Continual Improvement
Teamwork and Collaboration 
 
21,000+

Banked cord blood units since summer of 2004

98%

Average recovery rate of total nucleated cells

94.2%

Recovery rate of viable stem cells

99.1%

CD34+ Viability rate

We speak…
  • English
  • French
  • Chinese
  • Arabic
  • Tamil
  • Tagalog
  • Farsi
100%

Successful cord blood transplant rate

<0.1%

Extremely low processing failure rate

AABB Accredited

Health Canada Registered

FDA Registered

Our Experts

Dr. Nicholas Pairaudeau

Medical Director

Consultant, OB/GYN, North York General Hospital
Assistant Professor, OB/GYN, University of Toronto

Elias Kalouche

Vice President

International FACT Accreditation Inspector of cord blood and cellular therapy programs and a member of the FACT committee tasked to develop the 6th and 7th edition of the International Standards of Cord Blood Banking

Alla Pidgorna

Laboratory Manager

Co-author of “Effects of Interruptions of Controlled-Rate Freezing on the Viability of the Umbilical Cord Blood Stem Cells” published in Transfusion Journal 2015 Jan;55(1):70-78 [Study conducted by the research team at Progenics Cord Blood Cryobank]

Let’s get started